Literature DB >> 18766480

Functional outcome of femoral peri prosthetic fracture and revision hip arthroplasty: a matched-pair study from the New Zealand Registry.

Simon W Young1, Cameron G Walker, Rocco P Pitto.   

Abstract

BACKGROUND AND
PURPOSE: The number of periprosthetic fractures following total hip arthroplasty (THA) is increasing. There is, however, limited data on the functional outcome following these injuries. We analyzed functional outcome for revision THA following periprosthetic fracture, and compared this to the outcome of elective revision THA performed for aseptic loosening.
METHODS: 232 patients undergoing revision THA for femoral fracture were identified from the New Zealand National Registry. Functional outcome was measured using the Oxford 12 hip score (OHS). A reference group of 232 patients undergoing elective revision THA was selected and matched for age and sex.
RESULTS: Outcome was worse following revision THA for periprosthetic fracture than in reference patients (mean OHS: 29 vs. 24, p = 0.006). A higher 6-month mortality rate was seen in periprosthetic fracture patients (7.3% vs. 0.9%, p < 0.001), along with a higher likelihood of re-revision (7.3% vs. 2.6%, p = 0.06).
INTERPRETATION: This large comparative series of periprosthetic fractures following THA shows that patients with periprosthetic fracture have poorer functional outcome and higher death rates than patients undergoing revision THA for aseptic loosening.

Entities:  

Mesh:

Year:  2008        PMID: 18766480     DOI: 10.1080/17453670710015463

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  22 in total

1.  Femoral revision for periprosthetic fracture in total hip arthroplasty.

Authors:  Luke G Menken; Jose A Rodriguez
Journal:  J Clin Orthop Trauma       Date:  2019-12-14

2.  Outcome of periprosthetic femoral fractures following total hip replacement treated with polyaxial locking plate.

Authors:  M F Hoffmann; S Lotzien; T A Schildhauer
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-06

3.  Patient factors predict periprosthetic fractures after revision total hip arthroplasty.

Authors:  Jasvinder A Singh; Matthew R Jensen; David G Lewallen
Journal:  J Arthroplasty       Date:  2012-02-15       Impact factor: 4.757

4.  Outcomes following surgical treatment of periprosthetic femur fractures: a single centre series.

Authors:  Natasha Holder; Steve Papp; Wade Gofton; Paul E Beaulé
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

5.  Does femoral component loosening predispose to femoral fracture?: an in vitro comparison of cemented hips.

Authors:  Barton Harris; John R Owen; Jennifer S Wayne; William A Jiranek
Journal:  Clin Orthop Relat Res       Date:  2009-08-11       Impact factor: 4.176

6.  Vancouver B2 periprosthetic femoral fractures: a comparative study of stem revision versus internal fixation with plate.

Authors:  Mauro Spina; Andrea Scalvi
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-21

7.  Early results of the LPS™ limb preservation system in the management of periprosthetic femoral fractures.

Authors:  M Curtin; C Bryan; E Murphy; C G Murphy; W Curtin
Journal:  J Orthop       Date:  2016-10-25

8.  Vancouver type B2 and B3 periprosthetic fractures treated with revision total hip arthroplasty.

Authors:  Tomas Amenabar; Wael A Rahman; Vineet V Avhad; Ramiro Vera; Allan E Gross; Paul R Kuzyk
Journal:  Int Orthop       Date:  2015-08-25       Impact factor: 3.075

9.  Periprosthetic hip fractures: A review of the economic burden based on length of stay.

Authors:  Rebecca F Lyons; Robert P Piggott; William Curtin; Colin G Murphy
Journal:  J Orthop       Date:  2018-01-16

10.  Management of Vancouver Type-B2 and B3 Periprosthetic Femoral Fractures: Restoring Femoral Length via Preoperative Planning and Surgical Execution Using a Cementless, Tapered, Fluted Stem.

Authors:  José A Rodriguez; Zachary P Berliner; Carlos A Williams; Jonathan Robinson; Matthew S Hepinstall; H John Cooper
Journal:  JBJS Essent Surg Tech       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.